{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:41:37Z","timestamp":1763664097246,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmcl.2019.126759","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T02:49:59Z","timestamp":1572230999000},"page":"126759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Synthesis and evaluation of substituted 8,8-dimethyl-8H-pyrano[2,3-f]chromen-2-one derivatives as vasorelaxing agents"],"prefix":"10.1016","volume":"30","author":[{"given":"Sarita","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karishma","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debabrata","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-5925","authenticated-orcid":false,"given":"Feroz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"#cr-split#-10.1016\/j.bmcl.2019.126759_b0005.1","doi-asserted-by":"crossref","unstructured":"(a) Zhao L, Yuan X, Wang J, et al. A review on flavones targeting serine\/threonine protein kinases for potential anticancer drugs. Bioorg Med Chem, 2019, 27, 677-685. doi:10.1016\/j.bmc.2019.01.027","DOI":"10.1016\/j.bmc.2019.01.027"},{"key":"#cr-split#-10.1016\/j.bmcl.2019.126759_b0005.2","doi-asserted-by":"crossref","unstructured":"(b) Kumar D, Sharma P, Singh H, et al. The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Adv, 2017, 7, 36977-36999. doi:10.1039\/C7RA05441F.","DOI":"10.1039\/C7RA05441F"},{"key":"10.1016\/j.bmcl.2019.126759_b0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1517\/13543776.2013.801455","article-title":"Benzofuran derivatives: a patent review","volume":"23","author":"Dawood","year":"2013","journal-title":"Expert Opin Ther Patents"},{"key":"10.1016\/j.bmcl.2019.126759_h0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/med.10033","article-title":"Flavonoids: promising anticancer agents","volume":"23","author":"Ren","year":"2003","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2019.126759_h0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.07.034","article-title":"Recent discoveries of anticancer flavonoids","volume":"142","author":"Raffa","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0973-8258.41171","article-title":"Ageratum conyzoides L.: a review on its phytochemical and pharmacological profile","volume":"2","author":"Kamboj","year":"2008","journal-title":"Int J Greeen Pharma"},{"key":"10.1016\/j.bmcl.2019.126759_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.fitote.2013.07.003","article-title":"Phytochemistry and biological properties of glabridin","volume":"90","author":"Simmler","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmcl.2019.126759_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2012.11.056","article-title":"Osthole relaxes pulmonary arteries through endothelial phosphatidylinositol 3-kinase\/Akt-eNOS-NO signaling pathway in rats","volume":"699","author":"Yao","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2019.126759_b0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/np300824h","article-title":"Scopoletin and scopolin isolated from Artemisia iwayomogi suppress differentiation of osteoclastic macrophage RAW 264.7 cells by scavenging reactive oxygen species","volume":"76","author":"Lee","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2019.126759_b0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1248\/cpb.58.191","article-title":"Five new lignans from lyonia ovalifolia","volume":"58","author":"Kashima","year":"2010","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmcl.2019.126759_b0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/13543776.2012.678835","article-title":"Coumarin-based drugs: a patent review (2008-present)","volume":"22","author":"Kontogiorgis","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2019.126759_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/07352689.2011.616039","article-title":"Review scopoletin-a coumarin phytoalexin with medicinal properties","volume":"31","author":"Gnonlonfin","year":"2012","journal-title":"Crit Rev Plant Sci"},{"key":"10.1016\/j.bmcl.2019.126759_b0055","doi-asserted-by":"crossref","unstructured":"Singh H, Singh JV, Bhagat K, et al. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. Bioorg Med Chem Lett, 2019, 27, 3477\u20133510. doi:10.1016\/j.bmc.2019.06.033.","DOI":"10.1016\/j.bmc.2019.06.033"},{"key":"10.1016\/j.bmcl.2019.126759_h0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cbdd.12629","article-title":"Coumarin: a privileged scaffold for the design and development of antineurodegenerative agents","volume":"87","author":"Jameel","year":"2016","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2019.126759_h0070","doi-asserted-by":"crossref","first-page":"38892","DOI":"10.1039\/C5RA05643H","article-title":"Coumarins as privileged scaffold for anti-inflammatory drug development","volume":"5","author":"Grover","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2019.126759_h0075","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.2174\/1381612811319210013","article-title":"Current developments of coumarin compounds in medicinal chemistry","volume":"19","author":"Peng","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmcl.2019.126759_b0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejmech.2015.08.033","article-title":"Current developments of coumarin-based anti-cancer agents in medicinal chemistry","volume":"102","author":"Emamia","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0070","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","article-title":"Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies","volume":"101","author":"Thakur","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0075","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1016\/j.bmcl.2010.10.027","article-title":"Discovery of novel osthole derivatives as potential anti-breast cancer treatment","volume":"20","author":"You","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126759_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bmc.2012.10.059","article-title":"Synthesis and biological evaluation of scopoletin derivatives","volume":"21","author":"Cai","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0085","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.bmcl.2011.08.090","article-title":"Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents","volume":"21","author":"Yang","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126759_b0090","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00044-012-0159-y","article-title":"Synthesis and biological evaluation of resveratrol\u2013coumarin hybrid compounds as potential antitumor agents","volume":"22","author":"Shen","year":"2013","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2019.126759_b0095","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.bmc.2010.03.069","article-title":"Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents","volume":"18","author":"Belluti","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmech.2016.03.087","article-title":"Recent developments of C-4 substituted coumarin derivatives as anticancer agents","volume":"119","author":"Dandriyal","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0105","first-page":"389","article-title":"Mechanism of relaxation of rat aorta by scopoletin; an active constitutent of Artemisia capillaris","volume":"16","author":"Kwon","year":"2002","journal-title":"Kor J Ori Med Physiol Pathol"},{"key":"10.1016\/j.bmcl.2019.126759_b0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmcl.2005.10.013","article-title":"Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin\u2013resveratrol hybrids","volume":"16","author":"Vilar","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126759_b0115","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bmcl.2015.11.056","article-title":"Synthesis and fluorescent study of 5-phenyl furocoumarin derivatives as vasodilatory agents","volume":"26","author":"Wang","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126759_b0120","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00044-014-1303-7","article-title":"Synthesis and vasorelaxation evaluation of novel biphenyl-furocoumarin derivatives","volume":"24","author":"Wang","year":"2015","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2019.126759_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2016.09.018","article-title":"Glabridin-induced vasorelaxation: evidence for a role of BKCa channels and cyclic GMP","volume":"165","author":"Chanda","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2019.126759_b0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2003-37717","article-title":"Vasorelaxing properties and bio-guided fractionation of Cedrelopsis grevei","volume":"69","author":"Rakotoarison","year":"2003","journal-title":"Planta Med"},{"key":"10.1016\/j.bmcl.2019.126759_b0135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1568026615666150220112437","article-title":"Cardiovascular effects of coumarins besides their antioxidant activity","volume":"15","author":"Najmanov\u00e1","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmcl.2019.126759_b0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.biochi.2012.09.006","article-title":"In vitro platelet antiaggregatory properties of 4-methylcoumarins","volume":"94","author":"Mac\u00e1kov\u00e1","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bmcl.2019.126759_b0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0960-894X(02)00015-X","article-title":"Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives","volume":"12","author":"Campos-Toimil","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126759_b0150","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1016\/j.bmc.2011.08.037","article-title":"Design, synthesis and vasorelaxant evaluation of novel coumarins-pyrimidine hybrids","volume":"19","author":"Amin","year":"2011","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930722X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930722X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:31:40Z","timestamp":1760772700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X1930722X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0960894X1930722X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126759","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of substituted 8,8-dimethyl-8H-pyrano[2,3-f]chromen-2-one derivatives as vasorelaxing agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126759"}}